Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Bio-Techne (TECH) over the last 16 years, with Q4 2025 value amounting to $1.9 billion.

  • Bio-Techne's Non-Current Assets fell 739.36% to $1.9 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $7.9 billion, marking a year-over-year decrease of 619.97%. This contributed to the annual value of $245.7 million for FY2025, which is 216.4% down from last year.
  • Latest data reveals that Bio-Techne reported Non-Current Assets of $1.9 billion as of Q4 2025, which was down 739.36% from $1.9 billion recorded in Q3 2025.
  • In the past 5 years, Bio-Techne's Non-Current Assets registered a high of $2.2 billion during Q3 2023, and its lowest value of $207.9 million during Q2 2021.
  • In the last 5 years, Bio-Techne's Non-Current Assets had a median value of $1.8 billion in 2022 and averaged $1.5 billion.
  • As far as peak fluctuations go, Bio-Techne's Non-Current Assets skyrocketed by 2030.33% in 2023, and later tumbled by 818.27% in 2025.
  • Quarter analysis of 5 years shows Bio-Techne's Non-Current Assets stood at $1.7 billion in 2021, then rose by 4.88% to $1.8 billion in 2022, then grew by 19.01% to $2.1 billion in 2023, then dropped by 4.87% to $2.0 billion in 2024, then decreased by 7.39% to $1.9 billion in 2025.
  • Its last three reported values are $1.9 billion in Q4 2025, $1.9 billion for Q3 2025, and $245.7 million during Q2 2025.